Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: John Lacelle who wrote (668)	11/6/1998 6:43:00 AM
From: Cage Rattler	Read Replies (1) \| Respond to of 1255

John: Unfortunately it does appear CORX is heading down the tube. It would not shock me to see the next resistance at 30-cents, and when de-listing occurs, who knows -- chapter eleven anyone? Thus is the bleeding edge of medical technology. Guess the enormous volume and price drop last month was the subtile clue. It might prove interesting to hear about the "ongoing trials" -- bad news might flag insiders bailing out, along with the CFO. Those results were anticipated last June as I recall. Who knows? Any positive voices out there? Ciao, Ted